Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls
Centralizing procurement for prescription drugs has the potential to reduce drug spending by creating economies of scale and by improving purchasing power. In March 2019, the Chinese government launched a volume-based purchasing (VBP) pilot program using a competitive bidding process to purchase acc...
Saved in:
Main Authors: | Yilin Chen (Author), Xu Ji (Author), Hong Xiao (Author), Joseph M Unger (Author), Yi Cai (Author), Zongfu Mao (Author), Kai Yeung (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis
by: Xiaotong Wen, et al.
Published: (2021) -
Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
by: Hongfei Long, et al.
Published: (2022) -
Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
by: Ni Wang, et al.
Published: (2021) -
The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis
by: Ying Yang, et al.
Published: (2021) -
The impact of "4 + 7" volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
by: Ying Yang, et al.
Published: (2021)